Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Ponce

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacy and Pharmacology|March 10, 2004
Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit modelsAbraham Quezada, Jeff Larson, Martha French, et al.
Journal of Immunotoxicology|August 19, 2011
Alterations in regulatory T-cells: rediscovered pathways in immunotoxicologyEmanuela Corsini, Mohamed Oukka, Raymond Pieters, et al.
Current Medical Research and Opinion|February 5, 2015
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer riskHervé Lebrec, Rafael Ponce, Bradley D Preston, et al.
Plos Neglected Tropical Diseases|October 3, 2014
Sources and distribution of surface water fecal contamination and prevalence of schistosomiasis in a Brazilian villageRafael Ponce-Terashima, Amber M Koskey, Mitermayer G Reis, et al.
Environmental Research|February 7, 2009
Hair methylmercury levels of mummies of the Aleutian Islands, AlaskaG M Egeland, Rafael Ponce, Nicolas S Bloom, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsyNuntra Suwantarat, Donald M Dumford, Rafael Ponce-Terashima, et al.
International Journal of Toxicology|June 23, 2012
Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human interleukin-21 in cynomolgus macaques (Macaca fascicularis)Kimberly S Waggie, Matthew S Holdren, Kelly Byrnes-Blake, et al.
Regulatory Toxicology and Pharmacology : RTP|November 14, 2007
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?Janet Clarke, Christopher Hurst, Pauline Martin, et al.
Human Gene Therapy|August 22, 2022
Regulatory Consideration for the Nonclinical Safety Assessment of Gene TherapiesJeffrey S Moffit, Diann L Blanset, Jessica L Lynch, et al.
Environmental Microbiology Reports|November 1, 2014
Blautia and Prevotella sequences distinguish human and animal fecal pollution in Brazil surface watersAmber M Koskey, Jenny C Fisher, A Murat Eren, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacy and Pharmacology|March 10, 2004
Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit modelsAbraham Quezada, Jeff Larson, Martha French, et al.
Journal of Immunotoxicology|August 19, 2011
Alterations in regulatory T-cells: rediscovered pathways in immunotoxicologyEmanuela Corsini, Mohamed Oukka, Raymond Pieters, et al.
Current Medical Research and Opinion|February 5, 2015
Tumor necrosis factor, tumor necrosis factor inhibition, and cancer riskHervé Lebrec, Rafael Ponce, Bradley D Preston, et al.
Plos Neglected Tropical Diseases|October 3, 2014
Sources and distribution of surface water fecal contamination and prevalence of schistosomiasis in a Brazilian villageRafael Ponce-Terashima, Amber M Koskey, Mitermayer G Reis, et al.
Environmental Research|February 7, 2009
Hair methylmercury levels of mummies of the Aleutian Islands, AlaskaG M Egeland, Rafael Ponce, Nicolas S Bloom, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsyNuntra Suwantarat, Donald M Dumford, Rafael Ponce-Terashima, et al.
International Journal of Toxicology|June 23, 2012
Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human interleukin-21 in cynomolgus macaques (Macaca fascicularis)Kimberly S Waggie, Matthew S Holdren, Kelly Byrnes-Blake, et al.
Regulatory Toxicology and Pharmacology : RTP|November 14, 2007
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?Janet Clarke, Christopher Hurst, Pauline Martin, et al.
Human Gene Therapy|August 22, 2022
Regulatory Consideration for the Nonclinical Safety Assessment of Gene TherapiesJeffrey S Moffit, Diann L Blanset, Jessica L Lynch, et al.
Environmental Microbiology Reports|November 1, 2014
Blautia and Prevotella sequences distinguish human and animal fecal pollution in Brazil surface watersAmber M Koskey, Jenny C Fisher, A Murat Eren, et al.
Pageof 4